NYSE:MDTMedical Equipment
Medtronic Advances Cardiology And Diabetes Portfolio With New Approvals And Investment
Medtronic (NYSE:MDT) has made a substantial investment in Anteris Technologies to support next generation heart valve development and potential future collaborations.
The company secured European regulatory approval and completed initial U.S. clinical cases for its Affera Sphere-360 all in one mapping and pulsed field ablation catheter in atrial fibrillation care.
Medtronic also received FDA clearance for its MiniMed Go diabetes management system, which integrates multiple smart technologies...